Table 2.

Univariate analysis of prognostic factors for overall survival and progression-free survival

Factor	OS			PFS
	HR	P Value		HR	P Value
Sex (female vs. male)	1.091	0.576		1.051	0.78
Age	1.008	0.162		1.004	0.489
Mean tumor diameter (cm)	1.102	< 0.001		1.119	< 0.001
Albumin g/dL	0.987	0.265		0.995	0.667
Total bilirubin u mol/L	1.004	0.002		1.002	0.139
AFP > 400 ng/mL	1.868	< 0.001		1.941	< 0.001
Child-Pugh B	0.847	0.445		0.833	0.437
BCLC B	2.072	< 0.001		2.631	< 0.001
Hepatitis B	1.589	0.118		1.203	0.534
TACE-RFA	0.205	0		0.147	0
Number of tumors	1.089	0.446		1.089	0.488

OS overall survival, PFS progression-free survival, HR hazard ratio, AFP alpha-fetoprotein, BCLC Barcelona Clinic Liver Cancer, RFA radiofrequency ablation, TACE transarterial chemoembolization